A critical breakthrough in cancer investigation is occurring with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant suppressor protein is frequently disabled in many types of tumors, https://lingeriebookmark.com/story12019527/mini-antibodies-restore-p53-the-new-pathway-for-cancer-management